Antiviral Treatment of Patients with Recurrent Hepatitis C After Liver Transplantation with Pegylated Interferon

被引：0
|
作者：
Sven C. Schmidt
Marcus Bahra
Sandra Bayraktar
Thomas Berg
Maximilian Schmeding
Johann Pratschke
Peter Neuhaus
Ulf Neumann
机构：
[1] Universitätsmedizin Berlin,Klinik für Allgemein
[2] Universitätsmedizin Berlin,, Viszeral
来源：
Digestive Diseases and Sciences | 2010年 / 55卷
关键词：
Recurrent hepatitis C; Antiviral treatment; Liver transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2063 / 2069
页数：6
相关论文
共 50 条
  • [21] Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation
    Honda, Masaki
    Sugawara, Yasuhiko
    Watanabe, Takehisa
    Tateyama, Masakuni
    Tanaka, Motohiko
    Uchida, Koushi
    Kawabata, Seiichi
    Yoshii, Daiki
    Miura, Kouhei
    Isono, Kaori
    Hayashida, Shintaro
    Ohya, Yuki
    Yamamoto, Hidekazu
    Sasaki, Yutaka
    Inomata, Yukihiro
    HEPATOLOGY RESEARCH, 2017, 47 (11) : 1147 - 1154
  • [22] Perspective of antiviral therapeutics for hepatitis C after liver transplantation
    Cheng-Maw Ho
    Rey-Heng Hu
    Po-Huang Lee
    World Journal of Pharmacology, 2014, (04) : 193 - 198
  • [23] Treatment of recurrent hepatitis C following liver transplantation
    Bizollon T.
    Ducerf C.
    Baulieux J.
    Trepo C.
    Current Gastroenterology Reports, 1999, 1 (1) : 15 - 19
  • [24] Two Patients Treated With Simeprevir Plus Pegylated-Interferon and Ribavirin Triple Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation: Case Report
    Kawaoka, T.
    Imamura, M.
    Kan, H.
    Fujino, H.
    Fukuhara, T.
    Kobayashi, T.
    Honda, Y.
    Naeshiro, N.
    Hiramatsu, A.
    Tsuge, M.
    Hayes, C. N.
    Kawakami, Y.
    Aikata, H.
    Ochi, H.
    Ishiyama, K.
    Tashiro, H.
    Ohdan, H.
    Chayama, K.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (03) : 809 - 814
  • [25] Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation
    Issa, D.
    Eghtesad, B.
    Zein, N. N.
    Yerian, L.
    Cruise, M.
    Alkhouri, N.
    Adams, R.
    Hanouneh, I. A.
    INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE, 2016, 7 (01): : 38 - 45
  • [26] Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin
    Al-Hamoudi, Waleed
    Mohamed, Hazem
    Abaalkhail, Faisal
    Kamel, Yaser
    Al-Masri, Nasser
    Allam, Naglaa
    Alqahtani, Saleh
    Al-Sofayan, Mohammed
    Khalaf, Hatem
    Al-Sebayel, Mohammed
    Al-Jedai, Ahmed
    Abdo, Ayman
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (06) : 1848 - 1852
  • [27] Plasma cell hepatitis induced by the termination of antiviral therapy for recurrent hepatitis C after living donor liver transplantation
    Ueda, Yoshihide
    Yoshizawa, Atsushi
    Ogura, Yasuhiro
    Miyagawa-Hayashino, Aya
    Haga, Hironori
    Chiba, Tsutomu
    Uemoto, Shinji
    HEPATOLOGY RESEARCH, 2014, 44 (10) : E279 - E283
  • [28] Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin
    Waleed Al-hamoudi
    Hazem Mohamed
    Faisal Abaalkhail
    Yaser Kamel
    Nasser Al-Masri
    Naglaa Allam
    Saleh Alqahtani
    Mohammed Al-Sofayan
    Hatem Khalaf
    Mohammed Al-Sebayel
    Ahmed Al-jedai
    Ayman Abdo
    Digestive Diseases and Sciences, 2011, 56 : 1848 - 1852
  • [29] Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy
    Babatin, M
    Schindel, L
    Burak, KW
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (06) : 359 - 365
  • [30] Pegylated interferon α-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C
    Ross, AS
    Bhan, AK
    Pascual, M
    Thiim, M
    Cosimi, AB
    Chung, RT
    CLINICAL TRANSPLANTATION, 2004, 18 (02) : 166 - 173
12345